Table 1:

Patient characteristics

Oligodendrocytosis (n = 18)FCD I (n = 21)Oligodendrocytosis + FCD I (n = 7)P Value
Sex.78
    Male (%)9 (50%)12 (57.14%)3 (42.9%)
    Female (%)9 (50%)9 (42.9%)4 (57.1%)
Age at operation (mean) (SD) (yr)11.2 (4.6)9.9 (6.0)11.1 (5.6).71
Age at seizure onset (mean) (SD) (yr)6.2 (4.8)4.6 (4.9)2.44 (1.7).18
Duration of epilepsy (mean) (SD) (yr)6.3 (3.9)6.5 (4.1)10.4 (5.6).11
Frequency of seizures.26
    Daily (%)8 (44.4%)16 (76.2%)5 (71.4%)
    Monthly (%)3 (16.7%)1 (4.8%)0 (0%)
    Weekly (%)7 (38.9%)4 (19%)2 (28.6%)
Types of seizures.60
    FOWIA/FOWIA-BTCZ (%)12 (66.7%)10 (47.6%)3 (42.9%)
    FOWA/ FOWA-BTCZ (%)2 (11.1%)4 (19.0%)1 (14.3%)
    Epileptic spasms (%)4 (22.2%)5 (23.8%)3 (42.9%)
    Generalized (%)0 (0%)2 (9.5%)0 (0%)
Epileptiform discharges on video-EEG.95
    Focal (%)15 (83.3%)17(81.0%)6 (85.7%)
    No focal (%)3 (16.7%)4 (19.0%)1 (14.3%)
No. of AEDs (mean) SD)2 (0.8)2.2 (0.7)2.7 (0.8).13
  • Note:—AED indicates Anti-epileptic drugs; FOWIA, focal onset with impaired awareness; FOWIA-BTCZ, focal onset with impaired awareness of bilateral tonic clonic seizures; FOWA, focal onset with awareness; FOWA-BTCZ, focal onset with awareness of bilateral tonic clonic seizures.